Live Breaking News & Updates on Patient Responses

Stay updated with breaking news from Patient responses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EHC 2023: Medication Overuse Headache a Pain to Treat

Medication overuse headache is a common secondary order condition whose treatment requires behavioral intervention and education. ....

United States , Comunidad Autonoma De Cataluna , Judith Pijpers , Sait Ashina , Beth Israel Deaconess Medical Center , Leiden University Medical School , European Headache Congress , Best Treatment , Medscape Medical , Patient Responses , Drug Induced Headache , Rebound Headache , Medication Overuse Headache , Migraine Headache , Drug Withdrawal , Chronic Daily Headache , Pain Management , Botulinum Toxin , Botox Injection , Chronic Headache , Nonsteroidal Anti Inflammatory Drugs ,

Preventive Drug Lists Led to More Affordable Asthma Medication

The study indicated the potential of preventative drug lists (PDLs) as a strategy for those who have high deductible health plans to address both patient access and affordability of asthma care.

....

Annad Sinaiko , High Deductible Health , Patient Responses To Incentives In Health , National Drug Data File , National Bureau Of Economic Research , Health Savings Accounts , Davizro Photography , Public Health , High Deductible Health Plans , Medicare Advantage , National Drug Data File Plus , Patient Responses , Consumer Directed Health Plans , National Bureau , Economic Research , Asthma Medication , Preventative Drug Lists , Affordable Asthma Medication ,

Preventative Drug Lists Led to More Affordable Asthma Medication

This study indicated the potential of PDLs as a strategy for those that have HDHP-HSAs to address both patient access and affordability of asthma care.
....

Annad Sinaiko , National Drug Data File , Patient Responses To Incentives In Health , National Bureau Of Economic Research , Health Savings Accounts , High Deductible Health , Health Policy , Public Health , High Deductible Health Plans , Medicare Advantage , National Drug Data File Plus , Spending With Preventive Drug Lists , Asthma Medications , Patient Responses , Consumer Directed Health Plans , National Bureau , Economic Research ,

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology Annual Meeting held. | May 25, 2023 ....

United Kingdom , United States , Tafasitamab Monjuvi , Ponatinib Iclusig , Steven Stein , Macrogenics Inc , American Society Of Clinical Oncology , International Blood , Marrow Transplant Research , Takeda Pharmaceuticals International , Lymphoma Biology Translational Research , Takeda Pharmaceutical Company , Drug Administration , European Union , Incyte Corporation , Millennium Pharmaceuticals Inc , Xencor Inc , European Hematology Association , Exchange Commission , Clinical Oncology , Annual Meeting , Hybrid Congress , Chief Medical Officer , Activin Receptor Like Kinase , Hematologic Malignancies , Myelodysplastic Syndromes ,

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual ....

United Kingdom , United States , Tafasitamab Monjuvi , Gewinn Nur , Catalina Loveman , Ponatinib Iclusig , Steven Stein , Greg Shertzer , European Hematology Association , Lymphoma Biology Translational Research , Xencor Inc , Macrogenics Inc , Marrow Transplant Research , European Union , Millennium Pharmaceuticals Inc , Incyte Corporation , American Society Of Clinical Oncology , Takeda Pharmaceuticals International , Takeda Pharmaceutical Company , International Blood , Exchange Commission , Drug Administration , Clinical Oncology , Annual Meeting , Hybrid Congress , Chief Medical Officer ,